Written by: Jonathan Simmons | Last reviewed: May 2015.
Saidha S, Eckstein C, Calabresi PA. New and emerging disease modifying therapies for multiple sclerosis. Annals of the New York Academy of Sciences 2012;1247:117-37. • Rituxan timeline. Genentech. Available at: http://www.gene.com/gene/products/information/oncology/rituxan/timeline.html. Accessed 102312. • Hauser SL, Waubant E, Arnold DL, et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008;358:676-88. • Hawker K, O'Connor P, Freedman MS, et al. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol 2009;66:460-71.